ProPhase Labs, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.9M | $4.2M | $2.5M | $22.1M | $25.0M | $22.4M | $17.5M | $14.5M |
| Cost of Revenue | $7.9M | $3.2M | $1.7M | $7.9M | $8.4M | $8.2M | $6.2M | $5.7M |
| Gross Profit | $1.9M | $997.0K | $832.0K | $14.2M | $16.7M | $14.3M | $11.3M | $8.8M |
| Gross Margin | 19.7% | 23.7% | 33.0% | 64.2% | 66.6% | 63.6% | 64.6% | 60.9% |
| Operating Expenses | ||||||||
| Research & Development | $431.0K | $358.0K | $340.0K | $1.3M | $824.0K | $1.3M | $1.1M | $794.0K |
| SG&A Expense | $4.8M | $2.7M | $2.3M | $8.1M | $5.9M | $6.1M | $5.0M | $6.1M |
| Operating Income | $-4.0M | $-2.7M | $-3.6M | $-7.8M | $416.0K | $-1.1M | $-2.7M | $-3.6M |
| Operating Margin | -40.4% | -63.1% | -142.3% | -35.5% | 1.7% | -4.9% | -15.7% | -24.8% |
| Interest Expense | $54.0K | $213.0K | $18.0K | $10.0K | $13.0K | $0 | $0 | — |
| Pretax Income | $-3.7M | $-4.0M | $-2.1M | $-7.8M | $405.0K | $-1.1M | $-2.7M | $-3.5M |
| Income Tax Expense | $-1.4M | — | — | $0 | $0 | $0 | $0 | $-40.0K |
| Net Income | $40.6M | $-2.9M | $-3.6M | $-7.8M | $405.0K | $-1.1M | $-2.7M | $-3.5M |
| Net Margin | 411.4% | -68.2% | -143.0% | -35.5% | 1.6% | -4.9% | -15.5% | -24.1% |
| EPS (Basic) | $0.65 | $-0.04 | $-0.06 | $-0.12 | $0.01 | $-0.02 | $-0.05 | $0.00 |
| EPS (Diluted) | $0.65 | $-0.04 | $-0.06 | $-0.12 | $0.01 | $-0.02 | $-0.05 | $0.00 |
| Shares Outstanding (Basic) | 62.3M | 68.3M | 65.6M | 67.1M | 63.4M | 59.4M | 59.3M | 59.3M |
| Shares Outstanding (Diluted) | 62.8M | 68.3M | 65.6M | 67.1M | 65.1M | 59.4M | 59.3M | 59.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |